Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omega-3 Pretreatment in Elective PCI
NCT01723345Phase 3Unknown
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Feb 2012
- Primary completion
- Mar 2013
- Countries
- 1
01
Overview
A Phase 3 trial of omega-3 fatty acid in coronary arteriosclerosis, sponsored by Shiraz University of Medical Sciences. Status: unknown.
02
Drugs
omega-3 fatty acid
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on NCT01723345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01723345.